- Exchanges
- BSE, NSE
- Industry
- Hospital
- Issue
- Book building
Park Medi World IPO
₹147.95
−8.67% on listing
Listing-day close · NSE · 17 Dec 2025 · issue price ₹162
Park Medi World’s ₹920 crore IPO was priced at ₹162 a share. It listed on the NSE on 17 Dec 2025 and closed its first day at ₹147.95, down 8.67% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹920 Cr
- Fresh issue
- ₹770 Cr
- Offer for sale
- ₹150 Cr
- Lot size
- 92 shares
- Minimum investment
- ₹14,904
- Face value
- ₹2
- Registrar
- Kfin Technologies
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 6.25× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹6,997 Cr
- P/E (post-issue)
- 25.1
- EPS (post-issue)
- ₹6.44
- Price to book
- 6.1
- ROE
- 20.68%
- ROCE
- 17.47%
- Debt to equity
- 0.61
- EBITDA margin
- 26.71%
- PAT margin
- 15.30%
- Promoter holding
- 95.55% → 82.89%
Financials as of 31 Mar 2025, from the offer documents.
Listing
- Listing date
- 17 Dec 2025
- Issue price
- ₹162
- Open
- ₹158.80
- High
- ₹165.87
- Low
- ₹146.93
- Close
- ₹147.95
Listing day on the NSE. The close was −8.67% on the issue price.
FAQs
When did the Park Medi World IPO open and close?
It opened on 10 Dec 2025 and closed on 12 Dec 2025.
What was the Park Medi World IPO price?
The price band was ₹154–162 a share. The final issue price was ₹162.
What is the lot size and minimum investment?
One lot is 92 shares, ₹14,904 at ₹162 a share. Retail investors apply in whole lots.
How much did Park Medi World raise?
₹920 crore: ₹770 crore of new shares and ₹150 crore offered by existing shareholders.
How many times was the Park Medi World IPO subscribed?
6.25 times overall.
How did Park Medi World list?
It listed on the NSE on 17 Dec 2025 at ₹158.80 and closed the day at ₹147.95, down 8.67% on the ₹162 issue price.
Who is the registrar of the Park Medi World IPO?
Kfin Technologies handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app